Quantum BioPharma Ltd. QNTM
2.02 USD -0.21 (-9.42%)
At closeNov 10, 2026, 4:22 PM EST
2.00 -0.02 -0.99%
After hours · Nov 10, 4:22 PM ET
2.00 Day range 2.26
2.00 52-week range 12.42
- YTD
- -72.33%
- 1 year
- -75.92%
News
benzinga.com Quantum BioPharma Submits Supplement To Correct, Restate Special Resolution Regarding Class A Multiple Voting Shares, Class B Subordinate Voting Shares Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for…
benzinga.com Top Wall Street Forecasters Revamp Thermo Fisher Scientific Expectations Ahead Of Q3 Earnings Thermo Fisher reports Q3 earnings Oct. 21, with analysts expecting $6.40 EPS and $11.93B revenue; analysts remain bullish, raising price targets.
benzinga.com EXCLUSIVE: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug Trial Quantum BioPharma signed an agreement with Thermo Fisher to initiate a Phase 2 clinical trial for its multiple sclerosis therapy, Lucid-MS.
benzinga.com Quantum BioPharma’s Licensee Unbuzzd Wellness Announces Appointment Of Michael Zapolin As CEO Quantum BioPharma Ltd. (NASDAQ:QNTM) (FRA: 0K91) ("Quantum BioPharma"), today announced its licensee – Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind
benzinga.com Reported Earlier, Quantum BioPharma Plans To Leave Canadian Exchange While Keeping Nasdaq Listing Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FSE: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Lakewood-Amedex (NASDAQ:LABT) stock rose 38.0% to $3.45 during Monday's after-market session. The company's market cap stands at $5.4 million. Alamar Biosciences (NASDAQ:ALMR) stock rose 7.4%…
benzinga.com Rodman & Renshaw Initiates Coverage On Quantum BioPharma with Buy Rating, Announces Price Target of $8 Rodman & Renshaw analyst Michael King initiates coverage on Quantum BioPharma (NASDAQ:QNTM) with a Buy rating and announces Price Target of $8.
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers INVO Fertility (NASDAQ:IVF) shares increased by 163.4% to $2.56 during Monday's pre-market session. The company's market cap stands at $1.7 million. GlucoTrack (NASDAQ:GCTK) shares moved…
benzinga.com EXCLUSIVE: Quantum BioPharma Achieves Major Milestone With FDA Clearance for Multiple Sclerosis Trial FDA approves Quantum BioPharma's IND application for Lucid-MS, advancing its progressive multiple sclerosis treatment to Phase 2 trials.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Jupiter Neurosciences (NASDAQ:JUNS) stock rose 36.4% to $0.23 during Tuesday's pre-market session. The market value of their outstanding shares is at $7.9 million. Imunon (NASDAQ:IMNN) shares…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session 
benzinga.com Quantum BioPharma Momentum Score Surges As Investors Cheer Progress In MS Research Quantum BioPharma stock momentum surges as MS study hits 50% enrollment and early PET imaging data shows promising results.- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com Quantum BioPharma Announces U.S. District Court For The Southern District Of New York Rules Against CIBC World Markets, RBC Dominion Securities Joint Motion To Reject Quantum's Lawsuit Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech…
- benzinga.com Quantum BioPharma Submits IND Application To FDA For Lucid-21-302, Its New Drug Candidate For Treatment Of Multiple Sclerosis Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech…
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Quantum BioPharma Enters Into Binding LOI With Allucent To Support Planned Phase 2 Clinical Trial Of Lucid-MS For Treatment Of Multiple Sclerosis Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech…
benzinga.com Quantum BioPharma Q4 EPS $(0.71) Beats $(0.93) Estimate Quantum BioPharma (NASDAQ:QNTM) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of $(0.93) by 23.66 percent. This is a 65.53 percent increase over losses of…- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com Quantum BioPharma Publishes Data From Clinical Study Of NCT06505239 Of Its Dietary Supplement Product Unbuzzd To Evaluate Impacts Of Unbuzzd On Alcohol Intoxication, Alcohol Metabolism Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets…- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com Reported On March 11: Quantum BioPharma Provides Corporate Update; Announces That Further To Its News Release On March 10, 2026, The Company Has Revised The Terms Of The Debenture Units; Reduce The Conversion Price Per Share To $3.00; Increase The Number Of Warrants Included As Part Of Each Debenture Unit To 333.33; Reduce The Exercise Price Per Warrant Share To $3.75 https://www.globenewswire.com/news-release/2026/03/11/3254229/0/en/Quantum-BioPharma-Provides-Corporate-Update.html
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com Quantum BioPharma Shareholder Sues Canadian Imperial Bank Of Commerce, Royal Bank Of Canada, RBC Capital Markets Over Alleged Stock Manipulation Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"),understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in…
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com Quantum BioPharma To Broadcast Three-Part Series About Allegations Of Stock Market Manipulation Against Company Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma"), is pleased to announce that national television network CTV News' flagship investigative program W5 will air,…
- benzinga.com Quantum BioPharma Q3 EPS $(1.25) Misses $(0.08) Estimate Quantum BioPharma (NASDAQ:QNTM) reported quarterly losses of $(1.25) per share which missed the analyst consensus estimate of $(0.08) by 1462.5 percent. This is a 71.4 percent increase over losses of…
benzinga.com Quantum BioPharma Denies Unsubstantiated Securities Investigation Allegations, Vows Legal Action Against Law Firms Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets…
benzinga.com Reported Earlier: Quantum Biopharma Reveals Cash Reward Of Up To $7M for Proof Of Market Manipulation In Its Stock TORONTO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated…- benzinga.com Reported Earlier: Quantum BioPharma Sets Record Date Of October 27, 2025 For Litigation-Linked Contingent Value Rights Tied to Potential $700M Lawsuit Proceeds Quantum BioPharma Ltd.
- benzinga.com Quantum BioPharma Receives Two Key Final Reports Of Potential Breakthrough Drug For Multiple Sclerosis: 90-Day Oral Toxicity Study Report And Toxicokinetic Study Report For Lucid-21-302 Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets…
- benzinga.com Quantum BioPharma Secures Health Canada Product License For Qlarity Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets…
- benzinga.com Quantum BioPharma Wins Buy Rating And $45 Forecast From Kingswood On Promise Of MS Drug Lucid-MS Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets…
benzinga.com Why Quantum BioPharma (QNTM) Stock Is Soaring Today Shares of Quantum BioPharma are surging in Monday morning trading. The stock is higher following a series of positive updates regarding its lead drug candidate for multiple sclerosis.- benzinga.com Quantum BioPharma Q2 EPS $(3.23) Compared With $(0.08) YoY Quantum BioPharma (NASDAQ:QNTM) reported quarterly losses of $(3.23) per share which missed the analyst consensus estimate of $(0.07) by 4514.29 percent. This is a 3937.5 percent decrease over losses…
benzinga.com Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug Quantum Biopharma's subsidiary, Huge Biopharma Australia, has cleared a regulatory milestone for its neuroprotective compound, Lucid-MS, in a Phase 1 trial.- benzinga.com Quantum BioPharma Fights $700M Market Manipulation Case, Opposes Bank Dismissal Bid Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech…
- benzinga.com Quantum BioPharma-Backed Unbuzzd Launches $5M Reg D Offering With Crypto Option, Retains 25% Stake Until $1B Valuation Ahead of Potential IPO Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announced…
benzinga.com Quantum BioPharma Shares' Rollercoaster Day: What's Going On? The biopharmaceutical company last week announced it had purchased 2,000 shares of GameStop.
benzinga.com Quantum BioPharma Submits Breakthrough MS Drug Candidate To UK's ILAP Program To Accelerate Patient Access Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech…- benzinga.com Quantum Biopharma Announces Private Placement Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech…
- benzinga.com Quantum BioPharma Partners with Unbuzzd to Raise Up to $5M for Alcohol Metabolism Beverage Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces…
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com Quantum BioPharma Announces Clarification That It Has Not Changed Its Name To Unbuzzd Wellness Inc Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today…